News
FAIR project reaches new milestone as phase I clinical trial of innovative new drug begins
The FAIR project has reached another significant milestone with the start of a phase I clinical trial for a groundbreaking therapeutic intervention for respiratory infections.
Discover the future of nebulization: recording of the FAIR Course is now available
The FAIR project continues to drive innovation in respiratory infection therapies, and the recent ERS online course, “Virtual School of Nebulization of Drugs for Treatment
FAIR’s major advancements presented at the ERS Congress 2024
FAIR had the great opportunity to present its objectives and preliminary findings in a full symposium at the European Respiratory Society (ERS) Congress in Vienna, Austria
FAIR project to present a symposium at the ERS Congress 2024
Flagellin aerosol therapy as an immunomodulatory adjunct to the antibiotic treatment of drug-resistant bacterial pneumonia (FAIR) will present a symposium at this year’s ERS Congress,
FAIR News August 2022- End 2023
The FAIR project, which aimed to pave the way for the first-in-human phase I clinical trial with nebulized flagellin, is now entering the final stage
Listen to the recording of first webinar of FAIR
The first webinar of the FAIR consortium entitled Targeted immunomodulation in airway epithelium to treat pneumonia, took place on 12 January, 2023.